PFE trade ideas
Pfizer Analysis. 3 reasons to watch.Hello Everyone,
I hope you all had a good start to the New Year.
Pfizer (PFE) has been in the news a lot recently due to their vaccine. There may also be a few reasons to keep an eye on their stock price.
1) Support/Resistance- PFE ended the year with a pull-back. The price is currently being supported around $37. Price has hit resistance at $37 three times since May 2020. Price broke through the resistance in Nov 2020 and appears to be forming a new support in this range.
2) Fibonacci Retracement- This support/resistance area ($37) also coincides with a 61.8% retracement from the most recent low from Oct 2020 (see attached chart). Price has not closed below the 61.8% retracement as of writing.
3) MACD Divergence- Looking at the MACD/price chart, the MACD is diverging from the price. Hidden Bullish Divergence formed on the price chart/MACD at $37. This may further prove price has found a new support at $37.
I would personally like to see a close above the 50-day EMA prior to entering any trades so I will continue to watch closely.
Thank you for reading and please do your own research before trading
PFIZER (1 NOV 2001 - 1 NOV 2018)PFIZER stock is seen in the huge V formation formed between November 1, 2001 and November 1, 2018.
If you have any idea about what will happen next, please specify in the comments.
It can be ADAM-EVE or just a V formation.
My V formation target expectation is $ 71.
PFE - EW analysis - ABC cycle downPFE - It is choppy and expecting ABC zigzag down move, where B wave is in progress as either simple abc move or wxy complex correction. But once B wave will finish, it will be going down for C wave down.
Give thumbs up if you really like the trade idea.
Pfizer ready for another push up$PFE is still inside the intact uptrend.
RSI divergence with price shy below the 50 level. MACD slope turning, histogram moving North. Price action and a bounce from a fractal trendline.
PFIZERWednesday, 6 January 2021
10:55 AM (WIB)
PFIZER is on the way to distributes Vaccines over the world.
After escapes from the huge Descending Channel, Pfizer creates a new Ascending Channel with the best momentum to rise higher from now.
Best regards,
RyodaBrainless
"Live to Ride and Ride to Live"
PFE 37: Boring but good Risk/Reward in a dangerous market PFE is an enormously profitable company that is not in fashion with the momo crowd or the new kids chasing sexy names. It is however an A+ company with staying power and good dividend yield, a better alternative to bonds in today's near-zero interest rate. As SPY correction is highly likely, it is perhaps a place to park some cash.
Also, the market has shown some interest in routing into real economy stocks (with real revenue and profit). TGT, WMT, GE for instance.
Technically it has turned upwards, after a sharp and quick sell-off from 43, after all the covid vaccine news. 1st Target is 40.50
To be long around 37 or sell PCS of 37/33. If needed lunch money, one could also sell ATM weekly calls that give out a 2% weekly premium.
This is a plan, obviously not any sort of advice.
Pfizer Pfizer and BioNTech companies have offered to supply 50 million doses of their COVID-19 vaccine to Africa for healthcare workers. The vaccine will be delivered in batches from March to the end of 2021.
Meanwhile, Pfizer had broken through the downtrend resistance line and then tested it. The price moves in an ascending channel and the most pleasant entry point is 36.6 if you know what I mean.
BioNTech
Best regards EXCAVO
PFE stock to lookout this weekPFE stock should flip this week from sell to buy. The MACD should become neutral soon, RSI at good levels, Boolinger band too looking good for purchase.. I am very bullish for short term -( 1- 3 months).. Of course buy or sell at your own risk and price points..
Please note- I do own PFE stocks as of today.
Looking at potential upside for PFE - a new weekly high likely?Earnings announcement coming on Feb 1st - for the period ending December 20, 2020 - so I'm stalking cheap CALL options above the $40 price level.
Do you think they've made any money selling their COVID-19 vaccine? If so, will that profit be reported in the upcoming announcement?
I'm thinking yes, and yes, so I'm taking the small risk for major upside potential. Please share your thoughts on this idea. Give it to me straight, sugar-coating rots my teeth and makes me nauseous!
Thank you.
$PFE Currently Pfizer still stuck around this price after breakout ascending triangle and down to resistance become support TWO times .
For bullish-So far chart for daily looking for juicy.we can assuming to do some double bottom to make 52weeks higher.
For bearish-need to some bad news about vaccine $Pfizer
Latest news Pfizer get approval for emergency by WHO.First vaccine Covid -19 in the world .
DYOR.still new born here.
PFizer - Vaccine is effective ? Many countries buying vaccine from Pfizer ... Logically, Pfizer stock should be VERY BULLISH..
BUT the chart shows..
1) 0 BANKER VOLUME
2) MCDX Deadly Cross on 18 DEC.
3) FIFT -ve
4) Price below EMA50
5) Insiders/Investors have been reducing their positions.
In short, Not bullish at all... WHY ?
PFEMID-TERM: 4hr hidden bullish divergence developing at a major support which is also the .618 retrace. The stop loss is 2.5% under support and also below a potential gap fill. 5 Reward to risk. (Not financial advice)
PFE12/27/20 - 1d Time Frame
1. Price action at the 37.27 - 36.13 area
2. MACD histogram shows losing downward trend momentum
3. Stochastics at oversold level
**
I am hoping that price action will respect and bounce from 36.57 support and start playing above the 50ema while MACD crosses for a bullish move then price slowly go up and hit Target 1.
Disclaimer
My post in this channel should not be used as a replacement for investment advice from a qualified professional. All my post is for my own chart analysis practice, informational and entrainment purposes only as I am not a registered investment advisor and do not offer investment advice. You, the reader, bear responsibility for your own investment and trade decisions and should seek the advice of a qualified securities professional before making any investment or trade.
